KPoP, NCT06798909: Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients |
|
|
| Not yet recruiting | 3 | 360 | US | Valganciclovir (Pre-emptive CMV Therapy), Valganciclovir CMV Prophylaxis | University of California, San Francisco, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) | Cytomegalovirus (CMV), Kidney Transplant; Complications, Kidney Diseases | 01/29 | 06/31 | | |